Serge Rivest
Affiliations: | Université Laval, Ville de Québec, Québec, Canada |
Google:
"Serge Rivest"Mean distance: 16.93 (cluster 6) | S | N | B | C | P |
Children
Sign in to add trainee| Luc Vallieres | grad student | 1993-1998 | Université Laval (Physics Tree) |
| Nicolas Patrick Turrin | post-doc | 2002-2007 | Laval University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lecordier S, Pons V, Rivest S, et al. (2022) Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner. Frontiers in Immunology. 12: 813536 |
| Pons V, Rivest S. (2022) Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease. Pharmacological Reviews. 74: 1-17 |
| Al-Onaizi MA, Thériault P, Lecordier S, et al. (2021) fvEarly monocyte modulation by the non-erythropoietic peptide ARA 290 decelerates AD-like pathology progression. Brain, Behavior, and Immunity |
| Cisbani G, Rivest S. (2021) Targeting innate immunity to protect and cure Alzheimer's disease: opportunities and pitfalls. Molecular Psychiatry |
| Pons V, Lévesque P, Plante MM, et al. (2021) Conditional genetic deletion of CSF1 receptor in microglia ameliorates the physiopathology of Alzheimer's disease. Alzheimer's Research & Therapy. 13: 8 |
| Uyar O, Laflamme N, Piret J, et al. (2020) An Early Microglial Response is Needed to Efficiently Control Herpes Simplex Virus Encephalitis. Journal of Virology |
| Fani Maleki A, Cisbani G, Plante MM, et al. (2020) Muramyl dipeptide-mediated immunomodulation on monocyte subsets exerts therapeutic effects in a mouse model of Alzheimer's disease. Journal of Neuroinflammation. 17: 218 |
| Anwar S, Pons V, Rivest S. (2020) Microglia Purinoceptor P2Y6: An Emerging Therapeutic Target in CNS Diseases. Cells. 9 |
| Anwar S, Rivest S. (2020) Alzheimer's disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation. Expert Opinion On Therapeutic Targets. 1-14 |
| Pons V, Laflamme N, Préfontaine P, et al. (2020) Role of Macrophage Colony-Stimulating Factor Receptor on the Proliferation and Survival of Microglia Following Systemic Nerve and Cuprizone-Induced Injuries. Frontiers in Immunology. 11: 47 |